Geodon Richter

Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression Mostly Positive
Tue, 04/3/18 - 09:09 am
Allergan
Geodon Richter
Vraylar
bipolar disorder
Allergan's Vraylar launch a success, despite trial failure
BioPharma Dive
Tue, 08/9/16 - 10:40 am
Allergan
Vraylar
drug launches
clinical trials
antipsychotics
Geodon Richter
Allergan and Richter win FDA approval for a once-rejected schizophrenia pill
Fierce Biotech
Thu, 09/17/15 - 05:21 pm
Allergan
Geodon Richter
FDA
cariprazine
antipsychotic
bipolar disorder
schizophrenia
Richter and Actavis say Cariprazine effective on schizophrenia relapse
Yahoo/Reuters
Tue, 01/20/15 - 10:28 am
Actavis
Geodon Richter
cariprazine
schizophrenia
FDA declines to approve new Forest, Richter drug
Reuters
Thu, 11/21/13 - 08:27 am
FDA
Forest Labs
Geodon Richter
cariprazine
Forest Files Cariprazine NDA
NASDAQ.com
Wed, 12/5/12 - 10:22 am
Forest Labs
cariprazine
Geodon Richter
schizophrenia
Forest, Richter Schizophrenia Drug Met Clinical Trial Goals
Bloomberg
Tue, 02/28/12 - 10:06 am
Forest
Geodon Richter
schizophrenia
cariprazine
antipsychotics
Forest-Gedeon Richter drug misses overall goal
Marketwatch
Mon, 08/30/10 - 11:15 am
biopolar depression
cariprazine
Geodon Richter
Forest Labs